Previous close | 20.66 |
Open | 20.72 |
Bid | 20.67 x 1000 |
Ask | 20.73 x 1000 |
Day's range | 20.66 - 20.77 |
52-week range | 18.33 - 22.04 |
Volume | |
Avg. volume | 105,228 |
Market cap | N/A |
Beta (5Y monthly) | 1.03 |
PE ratio (TTM) | 2.65 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.19 (5.75%) |
Ex-dividend date | 31 May 2024 |
1y target est | N/A |
Insurance giant MetLife rebounded late last year and is putting up strong sales and profit numbers. Additionally, MetLife stock is up 50% over the past year and just below a fresh buy point. The upgraded 82 RS Rating means that MetLife stock topped 82% of all stocks for price performance this past year.
The decent earnings reports have helped the sector to survive the market rout seen last month.
MetLife ( NYSE:MET ) First Quarter 2024 Results Key Financial Results Revenue: US$16.1b (up 4.3% from 1Q 2023). Net...